These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17640107)

  • 21. Bayesian prediction intervals for assessing P-value variability in prospective replication studies.
    Vsevolozhskaya O; Ruiz G; Zaykin D
    Transl Psychiatry; 2017 Dec; 7(12):1271. PubMed ID: 29217835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moving in Parallel Toward a Modern Modeling Epistemology: Bayes Factors and Frequentist Modeling Methods.
    Rodgers JL
    Multivariate Behav Res; 2016; 51(1):30-4. PubMed ID: 26881955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian versus frequentist statistical inference for investigating a one-off cancer cluster reported to a health department.
    Coory MD; Wills RA; Barnett AG
    BMC Med Res Methodol; 2009 May; 9():30. PubMed ID: 19426561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fisher, Neyman, and Bayes at FDA.
    Rubin DB
    J Biopharm Stat; 2016; 26(6):1020-1024. PubMed ID: 27611988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian analysis of data from single case designs.
    Rindskopf D
    Neuropsychol Rehabil; 2014; 24(3-4):572-89. PubMed ID: 24365037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian perspectives for epidemiological research: I. Foundations and basic methods.
    Greenland S
    Int J Epidemiol; 2006 Jun; 35(3):765-75. PubMed ID: 16446352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern Statistical Methods for the Surgeon Scientist: The Clash of Frequentist versus Bayesian Paradigms.
    Lammers D; McClellan J
    Surg Clin North Am; 2023 Apr; 103(2):259-269. PubMed ID: 36948717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction to Bayesian reasoning.
    Hornberger J
    Int J Technol Assess Health Care; 2001; 17(1):9-16. PubMed ID: 11329848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.
    Agresti A; Min Y
    Biometrics; 2005 Jun; 61(2):515-23. PubMed ID: 16011699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating Relative Risk When Observing Zero Events-Frequentist Inference and Bayesian Credibility Intervals.
    Möller S; Ahrenfeldt LJ
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34064019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new prior for bayesian anomaly detection: application to biosurveillance.
    Shen Y; Cooper GF
    Methods Inf Med; 2010; 49(1):44-53. PubMed ID: 20027381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theory and practical use of Bayesian methods in interpreting clinical trial data: a narrative review.
    Ferreira D; Barthoulot M; Pottecher J; Torp KD; Diemunsch P; Meyer N
    Br J Anaesth; 2020 Aug; 125(2):201-207. PubMed ID: 32600802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. When significance becomes insignificant: Effect sizes and their uncertainties in Bayesian and frequentist frameworks as an alternative approach when analyzing ecotoxicological data.
    Feckler A; Low M; Zubrod JP; Bundschuh M
    Environ Toxicol Chem; 2018 Jul; 37(7):1949-1955. PubMed ID: 29508923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Count on your beliefs. Bayes--not the P value--measures credence].
    Taube A; Malmquist J
    Lakartidningen; 2001 Jul; 98(28-29):3208-11. PubMed ID: 11496808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues in applied statistics for public health bioterrorism surveillance using multiple data streams: research needs.
    Rolka H; Burkom H; Cooper GF; Kulldorff M; Madigan D; Wong WK
    Stat Med; 2007 Apr; 26(8):1834-56. PubMed ID: 17221940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian designs with frequentist and Bayesian error rate considerations.
    Wang YG; Leung DH; Li M; Tan SB
    Stat Methods Med Res; 2005 Oct; 14(5):445-56. PubMed ID: 16248347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries.
    Graham PL; Moran JL
    J Clin Epidemiol; 2012 May; 65(5):503-10. PubMed ID: 22265586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding and interpreting confidence and credible intervals around effect estimates.
    Hespanhol L; Vallio CS; Costa LM; Saragiotto BT
    Braz J Phys Ther; 2019; 23(4):290-301. PubMed ID: 30638956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bayesian statistics in medicine -- part II: main applications and inference].
    Montomoli C; Nichelatti M
    G Ital Nefrol; 2008; 25(4):422-31. PubMed ID: 18663689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.